Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1424999A Aminoalcohol derivatives
06/18/2003CN1424926A Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs
06/18/2003CN1424918A Remedies for diseases in association with decreasing in bone mass
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424914A Carbon dioxide enhancement of inhalation therapy
06/18/2003CN1424913A Antivirus medicine
06/18/2003CN1424912A Composition comprising camptothecin and pyrimidine derivative for the treatment of cancer
06/18/2003CN1424911A 焦虑方法 Anxiety method
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424909A Formulations for use in inhaler devices
06/18/2003CN1424908A Patch containing anti-inflammatory agent
06/18/2003CN1424907A Improved pharmaceutical formulations
06/18/2003CN1424875A Method of controlling zoological and aquatic plant growth
06/18/2003CN1424320A Hemsleyadine derivative and its preparing method and use as bactericidal agent
06/18/2003CN1424319A Extracts of cornus officinalis and its preparation and use
06/18/2003CN1424317A Structure and preparation of rhamnegin with xylopyranose branched chain as medicine
06/18/2003CN1424315A Ginkgo lactone compound and its preparation and medicinal composition containing it
06/18/2003CN1424313A Chuanxiong alkoxide derivative and its preparation and medicinal composition containing it and use thereof
06/18/2003CN1424112A Water soluble dressing for insoluble medicines and preparation thereof
06/18/2003CN1424105A Medicinal spray
06/18/2003CN1424096A Composite red sage root micro-capsules for cardio-cerebral diseases and its preparing method
06/18/2003CN1424080A Medicine for acute cerebral hemorrhage and its preparing method
06/18/2003CN1424070A Plaster
06/18/2003CN1424046A Use of Chinese angelica polysaccharide in oral colon orientation releasing pro-drug
06/18/2003CN1424045A Cell growth regulating factor B and preparation thereof
06/18/2003CN1424044A Gene medicine against mammitis of dairy cow
06/18/2003CN1424043A Kakonein eye drops
06/18/2003CN1424042A Crataegus leaves flavone tablets and their preparing method
06/18/2003CN1424041A Kakonein preparations and their production
06/18/2003CN1424040A Medicine against human papilloma virus
06/18/2003CN1424039A Drug composition containing cefazolin and beta-lactamase inhibitor
06/18/2003CN1424038A Preparation process for minoxidil spraying agent for treating bald and phalacrosis
06/18/2003CN1424037A Water soluble dressing materials of ziracitone and its salts and their preparation
06/18/2003CN1424036A Powder-injections of cyclonorfloxacin and its salts and their preparation
06/18/2003CN1424035A Lyophilized composition of nimodipine
06/18/2003CN1424034A Preparing method of oxiracetam injection and products thereof
06/18/2003CN1424033A Use of angiotensionase inhibitor against osteoporosis
06/18/2003CN1424032A Capsule agent with grape-seed extracts as raw material
06/18/2003CN1424031A Preparation containing Gingkolactone and its producing process
06/18/2003CN1424030A Medicines for preventing and treating retina and cornea blood vessel diseases
06/18/2003CN1424029A Medicines for preventing pneumoconiosis
06/18/2003CN1424028A Medicine for treating cancers and use thereof
06/18/2003CN1424027A Composite amino acid capsule and preparation thereof
06/18/2003CN1424026A Ambroxol hydrochloride containing hydroxypropyl beta-cyclodextrin and its preparation
06/18/2003CN1424025A Medicine against spinal canal restenosis and use thereof
06/18/2003CN1424020A Sun screener containing dibenzoyl methane derivative and amino substituted 2-hydroxy benzophenone derivative
06/18/2003CN1424018A San screener containing 1,3,5-triazine derivative, dibenzoylmethane derivative and amino substitued 2-hydroxy-benzene ketone derivative
06/18/2003CN1111541C Polymannuronic acid sulfate
06/18/2003CN1111537C Preparation of highly pure crystalline form of cefuroxime axetil
06/18/2003CN1111535C 42,52,82,8š�-tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridine-6,8 [7H]-dione derivatives for use in controlling endoparasites and method
06/18/2003CN1111531C Process for preparing 6-0-monoesters of castanospermine
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111527C Sesquilterpenic internal ester compound for antiulcer of alimentary tract
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/18/2003CN1111428C Compound ginkgo health product and preparing method
06/18/2003CN1111425C Plaster for treating hyperosteogeny
06/18/2003CN1111420C Exterior-applied medicine for treating lumbar intervertebral disk protrusion
06/18/2003CN1111419C Medicine for treating cardiovascular and cerebrovascular apoplexy and applexy aurae and its preparing process
06/18/2003CN1111418C Medicine for treating constipation and its preparing process
06/18/2003CN1111417C Medicine for enteritis and acute and chronic diarrhea and its preparing process
06/18/2003CN1111415C Medicine for hyperosteogeny and protrusion of intervertebral disc
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/18/2003CN1111413C Anion exchange resin-containing tablets
06/18/2003CN1111412C Thrombus clearing soft capsule and preparation technology thereof
06/18/2003CN1111411C Antibacterial clindamycin phosphate powder injection and its preparing process
06/18/2003CN1111410C Process for preparation of pharmaceutical composition
06/18/2003CN1111409C Use of cytosine in preparation of medicines for treatment of cancers
06/18/2003CN1111408C Pyridyl-and pyrimidyl-piperazines in treatment of substance abuse disorders
06/18/2003CN1111407C 抗癌组合物 Anticancer compositions
06/18/2003CN1111406C Anti-HIV composition containing imidazole derivative
06/18/2003CN1111405C Use of piracetam in preparation and for preventing and curing intracranial hypertension
06/18/2003CN1111404C Controlled release oxybutynin formulation
06/18/2003CN1111403C Secondary cataract inhibitor
06/18/2003CN1111402C Tramadol multiple unit formulations
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6580249 Intelligent serial battery charger and charging block
06/17/2003US6579989 Sulphostin analogue and process for producing sulphostin and its analogue
06/17/2003US6579983 5-cyano-2-aminopyrimidine derivatives
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579981 Treating herpes virus
06/17/2003US6579978 Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
06/17/2003US6579953 Graft polymers; improved flowability, greater hardness and less friability
06/17/2003US6579906 Stability, nontoxic; anthrax
06/17/2003US6579905 Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes
06/17/2003US6579903 Klainetins and their derivatives, method for their preparation and use thereof
06/17/2003US6579902 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide
06/17/2003US6579901 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579899 Composition for treatment of stress
06/17/2003US6579898 Compositions having improved bioavailability
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579895 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579893 Related thiazolidinediones
06/17/2003US6579892 Affective disorders; neurotic, stress and somatoform disorders and psychoses, e.g. schizophrenia 3-(3-(6-Methyl-1,2,3,4-tetrahydronaphth-2-ylamino)propylmercap to) -4-methyl-5-phenyl-1,2,4(4H)-triazole
06/17/2003US6579891 Metal ion chelating agent such as picolinic acid or derivatives; zinc finger protein in a canine lymphoma cell
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579887 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
1 ... 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 ... 7860